|
시장보고서
상품코드
1463775
세계의 소화관 스텐트 시장 : 시장 규모, 점유율 분석(제품별, 용도별, 재료별, 종류별, 최종사용자별) - 산업 수요 예측(-2030년)Gastrointestinal Stent Market Size and Share Analysis by Product, Application, Material, Type, End User - Global Industry Demand Forecast to 2030 |
||||||
시장 개요
세계의 소화관 스텐트 시장은 2023년에 5억 2,550만 달러의 매출을 기록했습니다. 2024-2030년 CAGR은 6.0%로, 최종적으로 2030년에는 7억 8,190만 달러에 달할 것으로 예측되고 있습니다. 이 성장은 소화기암 및 기타 소화기 질환의 발생이 증가하고 있는 것, 게실증 및 장 질병을 포함한 소화기 질환을 앓고 있는 고령화 인구가 증가하고 있는 것에 기인하고 있습니다.
주요 인사이트
2023년, 담도 스텐트 카테고리는 35%로 최대 수입 점유율을 차지했습니다.
폐쇄성 황달의 발생이 증가하고 있으며, 악성 질환 및 양성 질환에 기인할 가능성이 있으므로 패권을 유지할 것으로 예측됩니다.
자기 확장형 금속 스텐트(SEMS) 카테고리는 업계에서 최대 점유율 40%를 차지하고 있습니다.
이 스텐트는 높은 유효성, 보다 긴 효력, 삽입 용이성, 낮은 이동 또는 탈락 리스크 등의 이점이 있으므로 우위성을 유지할 것으로 예측됩니다.
2023년, 약물 용출 스텐트 카테고리는 소화관 스텐트 업계에서 보다 큰 매출 점유율을 창출했습니다.
이 카테고리는 표적 혈관의 재관류 감소 및 관련 질환의 위험성 감소 등의 이점이 있으므로 패권을 유지할 것으로 예측됩니다.
2023년에는 북미 지역의 판매고 점유율이 약50%로 가장 크고, 예측 기간 중 CAGR은 견고하게 추이할 전망입니다.
그 배경에는 가처분소득 및 높은 의료비, 소화관에 문제를 가지고 있는 인구의 고령화, 저침습수술의 높은 수용률 등이 있습니다.
세계의 소화관 스텐트 시장을 분석했으며, 시장의 기본 구조·최신 상황 및 주요 촉진·억제요인, 세계 전체 및 지역별·주요 국가의 시장 규모 동향 전망(금액 기반, 2017-2030년), 제품별·용도별·재료별·종류별·최종사용자별 상세 동향, 현재의 시장 경쟁 상황, 주요 기업의 개요 등을 조사하여 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 업계 전망
- 시장 역학
- 동향
- 촉진요인
- 억제요인/과제
- 촉진요인/억제요인의 영향 분석
- 신종 코로나바이러스 감염증(COVID-19)의 영향
- Porter's Five Forces 분석
제6장 세계 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 재료별(2017-2030년)
- SEMS 시장 매출 : 종류별(2017-2030년)
- 시장 매출 : 종류별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 재료별(2017-2030년)
- SEMS 시장 매출 : 종류별(2017-2030년)
- 시장 매출 : 종류별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아태평양 시장
제10장 라틴아메리카 시장
제11장 중동 및 아프리카 시장
제12장 미국 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 재료별(2017-2030년)
- SEMS 시장 매출 : 종류별(2017-2030년)
- 시장 매출 : 종류별(2017-2030년)
- 시장 매출 : 최종사용자별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카공화국 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 참여 기업과 제공 제품/서비스 리스트
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근 전략 개발 상황
제30장 기업 개요
- Boston Scientific Corporation
- Medtronic plc
- Becton, Dickinson and Company
- CONMED Corporation
- Olympus Corporation
- Cook Group Incorporated
- HOBBS MEDICAL INC.
- Merit Medical Systems
- W. L. Gore & Associates Inc.
제31장 부록
KSA 24.04.30Market Overview
The worldwide gastrointestinal stent market amassed USD 525.5 million in revenue in 2023. It is anticipated to experience a Compound Annual Growth Rate (CAGR) of 6.0% between 2024 and 2030, ultimately reaching USD 781.9 million by 2030. This growth can be credited to the increasing occurrence of gastrointestinal cancers and other peptic issues and the rising aging populace with gastrointestinal illnesses including diverticulosis and bowel sicknesses.
A major cause of death globally is stomach cancer which is a product of the gastrointestinal system. Most of the patients in recent years have been dying or sicker from chronic diseases such as colorectal cancer, esophageal cancer, and GI-related critical illnesses.
According to a new study released by the International Agency for Research on Cancer (IARC) in July 2020, colorectal cancer took away 35% of all deaths and 26% of all new incidences on the global map, and in 2018, IARC cites that there were approximately 4.8 million of colon cancer sufferers and 3.4 million
Furthermore, the increasing prevalence of Crohn's disease in all socio-economic sections of society stands behind the demand. As indicated by the Crohn's & Colitis Foundation, in 2020, three-quarters of all patients with Crohn's disease had one or more procedures at some point in their history.
Key Insights
In 2023, the biliary stent category had the largest income share of 35%.
It is projected to uphold its supremacy because of the growing occurrence of obstructive jaundice, which can outcome from malignant or benign disease.
Biliary stents are utilized to cure obstructions in the biliary tree or biliary leaks.
Minimally invasive endoscopic stent placement is now the most effective treatment choice for serious benign bile duct strictures.
The Self-expanding metal stents category had the largest share of 40% in the industry.
They are projected to uphold supremacy because of benefits such as high effectiveness, lengthier potency, ease of insertion, and low migration or dislodgment risk.
Such stents are utilized for handling benign gastrointestinal leaks and perforations.
Metal stents are characteristically made of nitinol, stainless steel, and cobalt-chromium, offering backing to keep the GI tract open for unobstructed drainage.
The drug-eluting stent category had a larger revenue share in the gastrointestinal stent market in 2023.
In 2023, the drug-eluting stent category generated a larger revenue share in the gastrointestinal stent industry.
The category is also projected to uphold its supremacy because of benefits such as decreased target-vessel revascularization and reduced danger of associated diseases.
Such stents efficiently release medication and have seen improvements like biodegradability.
The slow release of medicine is a major advantage contributing to the efficiency of drug-eluting stents.
In 2023, the North American region had the largest revenue share of approximately 50%, with prospects of strong CAGR development over the projection period.
Reasons propelling this include high disposable income, healthcare spending, a huge aging populace with gastrointestinal problems, and a high acceptance rate of minimally invasive operations.
The region's market growth will be driven by the existence of an ideal after-payment structure and the emergence of new cases of GI diseases as well.
The Canadian market looks very promising because the emerging medical equipment infrastructure, government initiatives, as well as the high demand for minimally invasive surgeries, are the factors contributing to this development.
The vast European market is anticipated to demonstrate high growth powered by the growing healthcare infrastructure advancements, as well as the increase in the number of chronic diseases and favorable reimbursement policies.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by material
- 1.4.4. Market size breakdown, by type
- 1.4.5. Market size breakdown, by end user
- 1.4.6. Market size breakdown, by region
- 1.4.7. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product (2017-2030)
- 6.3. Market Revenue, by Application (2017-2030)
- 6.4. Market Revenue, by Material (2017-2030)
- 6.4.1. SEMSs market revenue, by type (2017-2030)
- 6.5. Market Revenue, by Type (2017-2030)
- 6.6. Market Revenue, by End User (2017-2030)
- 6.7. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product (2017-2030)
- 7.3. Market Revenue, by Application (2017-2030)
- 7.4. Market Revenue, by Material (2017-2030)
- 7.4.1. SEMSs market revenue, by type (2017-2030)
- 7.5. Market Revenue, by Type (2017-2030)
- 7.6. Market Revenue, by End User (2017-2030)
- 7.7. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product (2017-2030)
- 8.3. Market Revenue, by Application (2017-2030)
- 8.4. Market Revenue, by Material (2017-2030)
- 8.4.1. SEMSs market revenue, by type (2017-2030)
- 8.5. Market Revenue, by Type (2017-2030)
- 8.6. Market Revenue, by End User (2017-2030)
- 8.7. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product (2017-2030)
- 9.3. Market Revenue, by Application (2017-2030)
- 9.4. Market Revenue, by Material (2017-2030)
- 9.4.1. SEMSs market revenue, by type (2017-2030)
- 9.5. Market Revenue, by Type (2017-2030)
- 9.6. Market Revenue, by End User (2017-2030)
- 9.7. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product (2017-2030)
- 10.3. Market Revenue, by Application (2017-2030)
- 10.4. Market Revenue, by Material (2017-2030)
- 10.4.1. SEMSs market revenue, by type (2017-2030)
- 10.5. Market Revenue, by Type (2017-2030)
- 10.6. Market Revenue, by End User (2017-2030)
- 10.7. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product (2017-2030)
- 11.3. Market Revenue, by Application (2017-2030)
- 11.4. Market Revenue, by Material (2017-2030)
- 11.4.1. SEMSs market revenue, by type (2017-2030)
- 11.5. Market Revenue, by Type (2017-2030)
- 11.6. Market Revenue, by End User (2017-2030)
- 11.7. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product (2017-2030)
- 12.3. Market Revenue, by Application (2017-2030)
- 12.4. Market Revenue, by Material (2017-2030)
- 12.4.1. SEMSs market revenue, by type (2017-2030)
- 12.5. Market Revenue, by Type (2017-2030)
- 12.6. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product (2017-2030)
- 13.3. Market Revenue, by Application (2017-2030)
- 13.4. Market Revenue, by Material (2017-2030)
- 13.4.1. SEMSs market revenue, by type (2017-2030)
- 13.5. Market Revenue, by Type (2017-2030)
- 13.6. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product (2017-2030)
- 14.3. Market Revenue, by Application (2017-2030)
- 14.4. Market Revenue, by Material (2017-2030)
- 14.4.1. SEMSs market revenue, by type (2017-2030)
- 14.5. Market Revenue, by Type (2017-2030)
- 14.6. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product (2017-2030)
- 15.3. Market Revenue, by Application (2017-2030)
- 15.4. Market Revenue, by Material (2017-2030)
- 15.4.1. SEMSs market revenue, by type (2017-2030)
- 15.5. Market Revenue, by Type (2017-2030)
- 15.6. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product (2017-2030)
- 16.3. Market Revenue, by Application (2017-2030)
- 16.4. Market Revenue, by Material (2017-2030)
- 16.4.1. SEMSs market revenue, by type (2017-2030)
- 16.5. Market Revenue, by Type (2017-2030)
- 16.6. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product (2017-2030)
- 17.3. Market Revenue, by Application (2017-2030)
- 17.4. Market Revenue, by Material (2017-2030)
- 17.4.1. SEMSs market revenue, by type (2017-2030)
- 17.5. Market Revenue, by Type (2017-2030)
- 17.6. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product (2017-2030)
- 18.3. Market Revenue, by Application (2017-2030)
- 18.4. Market Revenue, by Material (2017-2030)
- 18.4.1. SEMSs market revenue, by type (2017-2030)
- 18.5. Market Revenue, by Type (2017-2030)
- 18.6. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product (2017-2030)
- 19.3. Market Revenue, by Application (2017-2030)
- 19.4. Market Revenue, by Material (2017-2030)
- 19.4.1. SEMSs market revenue, by type (2017-2030)
- 19.5. Market Revenue, by Type (2017-2030)
- 19.6. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product (2017-2030)
- 20.3. Market Revenue, by Application (2017-2030)
- 20.4. Market Revenue, by Material (2017-2030)
- 20.4.1. SEMSs market revenue, by type (2017-2030)
- 20.5. Market Revenue, by Type (2017-2030)
- 20.6. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product (2017-2030)
- 21.3. Market Revenue, by Application (2017-2030)
- 21.4. Market Revenue, by Material (2017-2030)
- 21.4.1. SEMSs market revenue, by type (2017-2030)
- 21.5. Market Revenue, by Type (2017-2030)
- 21.6. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product (2017-2030)
- 22.3. Market Revenue, by Application (2017-2030)
- 22.4. Market Revenue, by Material (2017-2030)
- 22.4.1. SEMSs market revenue, by type (2017-2030)
- 22.5. Market Revenue, by Type (2017-2030)
- 22.6. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product (2017-2030)
- 23.3. Market Revenue, by Application (2017-2030)
- 23.4. Market Revenue, by Material (2017-2030)
- 23.4.1. SEMSs market revenue, by type (2017-2030)
- 23.5. Market Revenue, by Type (2017-2030)
- 23.6. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product (2017-2030)
- 24.3. Market Revenue, by Application (2017-2030)
- 24.4. Market Revenue, by Material (2017-2030)
- 24.4.1. SEMSs market revenue, by type (2017-2030)
- 24.5. Market Revenue, by Type (2017-2030)
- 24.6. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product (2017-2030)
- 25.3. Market Revenue, by Application (2017-2030)
- 25.4. Market Revenue, by Material (2017-2030)
- 25.4.1. SEMSs market revenue, by type (2017-2030)
- 25.5. Market Revenue, by Type (2017-2030)
- 25.6. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product (2017-2030)
- 26.3. Market Revenue, by Application (2017-2030)
- 26.4. Market Revenue, by Material (2017-2030)
- 26.4.1. SEMSs market revenue, by type (2017-2030)
- 26.5. Market Revenue, by Type (2017-2030)
- 26.6. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product (2017-2030)
- 27.3. Market Revenue, by Application (2017-2030)
- 27.4. Market Revenue, by Material (2017-2030)
- 27.4.1. SEMSs market revenue, by type (2017-2030)
- 27.5. Market Revenue, by Type (2017-2030)
- 27.6. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product (2017-2030)
- 28.3. Market Revenue, by Application (2017-2030)
- 28.4. Market Revenue, by Material (2017-2030)
- 28.4.1. SEMSs market revenue, by type (2017-2030)
- 28.5. Market Revenue, by Type (2017-2030)
- 28.6. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Boston Scientific Corporation
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Medtronic plc
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Becton, Dickinson and Company
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. CONMED Corporation
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Olympus Corporation
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Cook Group Incorporated
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. HOBBS MEDICAL INC.
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Merit Medical Systems
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. W. L. Gore & Associates Inc.
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
